<table border="1"><tr><th>Other names</th><td>Carcinoma of the prostate</td></tr><tr><th>Specialty</th><td>Oncology, urology</td></tr><tr><th>Symptoms</th><td>None, difficulty urinating, blood in the urine, pain in the pelvis, back, or when urinating</td></tr><tr><th>Usual onset</th><td>Age &gt; 50</td></tr><tr><th>Risk factors</th><td>Older age, family history, race</td></tr><tr><th>Diagnostic method</th><td>Tissue biopsy, medical imaging</td></tr><tr><th>Differential diagnosis</th><td>Benign prostatic hyperplasia</td></tr><tr><th>Treatment</th><td>Active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy</td></tr><tr><th>Prognosis</th><td>5-year survival rate 99% (US)</td></tr><tr><th>Frequency</th><td>1.2 million new cases (2018)</td></tr><tr><th>Deaths</th><td>359,000 (2018)</td></tr></table>